![Jennifer Simpson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Simpson
Directeur Général chez
SUN BIOPHARMA INC
Fortune : - $ au 31/05/2026
Profil
Dr. Jennifer K.
Simpson is a President, Chief Executive Officer & Director at Panbela Therapeutics, Inc. and a Lead Independent Director at Eagle Pharmaceuticals, Inc. She is on the Board of Directors at Panbela Therapeutics, Inc. and Eagle Pharmaceuticals, Inc. Dr. Simpson was previously employed as a Chairman by LadRx Corp., a President, Chief Executive Officer & Director by BGH Medical Products, a VP-Global Marketing & Oncology Brand by ImClone Systems, Inc., and a Product Director-Oncology Therapeutics Marketing by Centocor Ortho Biotech, Inc. She received her undergraduate degree from State University of New York at Buffalo, a graduate degree from Rochester Christian University and a doctorate degree from the University of Pittsburgh.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LADRX CORPORATION 0,01% | 28/03/2025 | 25 ( 0,01% ) | 0 $ | 31/05/2026 |
Postes actifs de Jennifer Simpson
| Sociétés | Poste | Début |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/08/2019 |
| SUN BIOPHARMA INC | Directeur Général | 16/07/2020 |
Anciens postes connus de Jennifer Simpson
| Sociétés | Poste | Fin |
|---|---|---|
| LADRX CORPORATION | Président | 28/07/2025 |
| DELCATH SYSTEMS, INC. | Directeur Général | 01/06/2020 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01/01/2011 |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Sales & Marketing | 01/01/2008 |
Formation de Jennifer Simpson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
49
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
LadRx Corp.
 LadRx Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development oncology company | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Biotech, Inc.
Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Panbela Therapeutics, Inc.
 Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
